Delivery Order SPE2DB22D9353-SPE2DB25FX2BP
- Not listed
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Avastin 400 mg/16 mL vials with a ceiling value of $8,709.44. This delivery order, awarded on July 24, 2025, represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $2,291.48 to DMS Pharmaceutical Group Inc. for the supply of Avastin 100 mg/4 mL vials on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside...
- This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,416.34, is for the delivery of Avastin 100 mg/4 ml vial 4 ml to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $77,721.84 firm fixed-price delivery order is for the supply of Avastin (bevacizumab) 400 mg/16 mL vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,387.80 contract is for the delivery of Avastin 100 mg/4 ml vials and has an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,387.80, is for the delivery of Avastin 100 mg/4 ml vials, a prescription cancer medication. The contract type is firm fixed price and has an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Avastin 100 mg/4 ml vials. The $5,626.40 order is for the delivery of this pharmaceutical item to the Park Ridge, Illinois location by November 27, 2023. DMS Pharmaceutical Group holds this indefinite delivery contract with the Defense Logistics Agency to supply various medical products with a potential value of up to $5 million...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,582.96 contract is for the delivery of Avastin 100 mg/4 ml vials to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,827.48 contract is for the delivery of Avastin 400 mg/16 ml vials. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,387.80 contract is for the delivery of Avastin 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,010.09 to DMS Pharmaceutical Group Inc. for the supply of Avastin 100 mg/4 mL vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a single shipment of this oncology medication to support military healthcare requirements. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business. DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, is the awardee and serves as a critical pharmaceutical distributor to the Defense Logistics Agency. This delivery order is issued under the company's substantial Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal agencies, with an established track record of pharmaceutical product delivery to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/8/25 |